Cargando…
Anti-CV2/CRMP5 Paraneoplastic Chorea Effectively Managed with Intravenous Amantadine
BACKGROUND: Paraneoplastic chorea is typically a subacute progressive hyperkinetic movement disorder. The mainstay of treatment is managing the underlying neoplasm. However, the clinical course may be variable, and effective symptomatic management can precede the start of cancer treatment. CASE REPO...
Autores principales: | Ha, Jongmok, Na, Boo Suk, Ahn, Jong Hyeon, Kim, Minkyeong, Kim, Jae Woo, Lee, Jae Hyeok, Cho, Jin Whan, Kim, Ji Sun, Youn, Jinyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia University Libraries/Information Services
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790010/ https://www.ncbi.nlm.nih.gov/pubmed/31656691 http://dx.doi.org/10.7916/tohm.v0.701 |
Ejemplares similares
-
Paraneoplastic Chorea Managed with Intravenous Amantadine
por: Doher, Nicholas, et al.
Publicado: (2019) -
Author Response to Letter to the Editor
por: Ha, Jongmok, et al.
Publicado: (2019) -
An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes
por: Wang, Sai, et al.
Publicado: (2023) -
Preliminary Study of Intravenous Amantadine Treatment for Ataxia Management in Patients with Probable Multiple System Atrophy with Predominant Cerebellar Ataxia
por: Youn, Jinyoung, et al.
Publicado: (2012) -
Paraneoplastic Limbic Encephalitis Associated with Anti-CV2/CRMP5 Antibodies Secondary to Thymoma in an Adolescent
por: Ibrahim Ismail, Ismail, et al.
Publicado: (2020)